Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Vimseltinib |
Trade Name | |
Synonyms | DCC-3014|DCC3014|DCC 3014|DP-6865 |
Drug Descriptions |
Vimseltinib (DCC-3014) inhibits CSF1R, potentially resulting in increased anti-tumor immune response in combination with other agents (PMID: 29679908, PMID: 34433663). |
DrugClasses | CSF1R Inhibitor 28 |
CAS Registry Number | 1628606-05-2 |
NCIT ID | C175876 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + Vimseltinib | Avelumab Vimseltinib | 0 | 1 |
unspecified PD-1 antibody + Vimseltinib | Vimseltinib unspecified PD-1 antibody | 0 | 0 |
Vimseltinib | Vimseltinib | 0 | 2 |